The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. (Q53574858)

15 May 2018

title

The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. (English)

1 reference

15 May 2018

0 references

6

Shahrokh F Shariat

1 reference

15 May 2018

author name string

Oliver Engel

1

1 reference

15 May 2018

Armin Soave

2

1 reference

15 May 2018

Sven Peine

3

1 reference

15 May 2018

Luis A Kluth

4

1 reference

15 May 2018

Marianne Schmid

5

1 reference

15 May 2018

Roland Dahlem

7

1 reference

15 May 2018

Margit Fisch

8

1 reference

15 May 2018

Michael Rink

9

1 reference

15 May 2018

publication date

18 March 2015

1 reference

15 May 2018

published in

World Journal of Urology

1 reference

15 May 2018

volume

33

1 reference

15 May 2018

issue

11

1 reference

15 May 2018

page(s)

1769-1776

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s00345-015-1531-6

exact match

0 references

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Predictors of cancer-specific mortality after disease recurrence following radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Biomolecular predictors of urothelial cancer behavior and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

AB0 blood group and prognosis in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Do blood groups have effect on prognosis of patients undergoing radical cystectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

ABO blood group and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

The Rh protein family: gene evolution, membrane biology, and disease association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients

21 January 2018

1 reference

12 December 2020

Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.

1 reference

12 December 2020

Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy

1 reference

12 December 2020

ABO blood group: old dogma, new perspectives

1 reference

12 December 2020

Barrettʼs, blood groups and progression to oesophageal cancer

1 reference

12 December 2020

Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma

1 reference

12 December 2020

ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma

1 reference

12 December 2020

ABO blood groups are not associated with treatment response and prognosis in patients with local advanced non- small cell lung cancer

1 reference

12 December 2020

Rhesus D-phenotype does not provide prognostic information additional to TNM staging in gastric cancer patients

1 reference

12 December 2020

Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma

1 reference

12 December 2020

Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.

1 reference

12 December 2020

Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer

1 reference

12 December 2020

Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition

1 reference

12 December 2020

10.1007/S00345-015-1531-6

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018